MIT Technology Review explores how AstraZeneca and others use AI to compress drug discovery and target previously untreatable diseases.
More than 173 AI-originated drug programs are in clinical development as of early 2026, with the first potential FDA approval…
Kordata Dynamics emerges from stealth with an AI platform that processes neural data to accelerate and improve precision clinical trials…